These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses. Bowness P; Moss PA; Rowland-Jones S; Bell JI; McMichael AJ Eur J Immunol; 1993 Jul; 23(7):1417-21. PubMed ID: 8391985 [TBL] [Abstract][Full Text] [Related]
23. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. VI. Migration and activity in vivo in acute and persistent infection. Byrne JA; Oldstone MB J Immunol; 1986 Jan; 136(2):698-704. PubMed ID: 2416821 [TBL] [Abstract][Full Text] [Related]
24. Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection. Speiser DE; Kyburz D; Stübi U; Hengartner H; Zinkernagel RM J Immunol; 1992 Aug; 149(3):972-80. PubMed ID: 1634779 [TBL] [Abstract][Full Text] [Related]
25. Restricted alpha/beta receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: selection for CDR3-related sequences. Snodgrass HR; Fisher AM; Bruyns E; Bogen B Eur J Immunol; 1992 Aug; 22(8):2169-72. PubMed ID: 1379189 [TBL] [Abstract][Full Text] [Related]
26. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422 [TBL] [Abstract][Full Text] [Related]
27. Analysis of T cell receptors specific for recognition of class IB antigens. Lowen LC; Aldrich CJ; Forman J J Immunol; 1993 Dec; 151(11):6155-65. PubMed ID: 8245458 [TBL] [Abstract][Full Text] [Related]
29. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501 [TBL] [Abstract][Full Text] [Related]
30. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas. Ikeda H; Sato N; Matsuura A; Kikuchi K Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386 [TBL] [Abstract][Full Text] [Related]
31. Characterization of virus-specific cytotoxic T cell clones from allogeneic bone marrow chimeras. Pircher H; Baenziger J; Schilham M; Sado T; Kamisaku H; Hengartner H; Zinkernagel RM Eur J Immunol; 1987 Feb; 17(2):159-66. PubMed ID: 3493906 [TBL] [Abstract][Full Text] [Related]
32. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules. Hengel H; Burke K; Kyburz D; Zinkernagel RM; Koszinowski UH J Immunol; 1995 May; 154(9):4557-64. PubMed ID: 7722309 [TBL] [Abstract][Full Text] [Related]
33. Immunodominance correlates with T-cell receptor (alpha beta) gene usage in the class II-restricted response to influenza haemagglutinin. Smith CA; Graham CM; Thomas DB Immunology; 1994 Jul; 82(3):343-50. PubMed ID: 7959866 [TBL] [Abstract][Full Text] [Related]
34. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant. Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346 [TBL] [Abstract][Full Text] [Related]
35. Conserved V(D)J junctional sequence of cross-reactive cytotoxic T cell receptor idiotype and the effect of a single amino acid substitution. Hirama T; Takeshita S; Matsubayashi Y; Iwashiro M; Masuda T; Kuribayashi K; Yoshida Y; Yamagishi H Eur J Immunol; 1991 Feb; 21(2):483-8. PubMed ID: 1705514 [TBL] [Abstract][Full Text] [Related]
36. Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule. Yanagi Y; Tishon A; Lewicki H; Cubitt BA; Oldstone MB J Virol; 1992 Apr; 66(4):2527-31. PubMed ID: 1372370 [TBL] [Abstract][Full Text] [Related]
37. Restricted T cell receptor expression by human T cell clones specific for mycobacterial 65-kDa heat-shock protein: selective in vivo expansion of T cells bearing defined receptors. Henwood J; Loveridge J; Bell JI; Gaston JS Eur J Immunol; 1993 Jun; 23(6):1256-65. PubMed ID: 7684683 [TBL] [Abstract][Full Text] [Related]
38. Polymorphism of cytotoxic T-lymphocyte clones that recognize a defined nine-amino-acid immunodominant domain of lymphocytic choriomeningitis virus glycoprotein. Joly E; Salvato M; Whitton JL; Oldstone MB J Virol; 1989 May; 63(5):1845-51. PubMed ID: 2467990 [TBL] [Abstract][Full Text] [Related]
39. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta. Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476 [TBL] [Abstract][Full Text] [Related]
40. Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T lymphocytes. Bachmann MF; Lutz MB; Layton GT; Harris SJ; Fehr T; Rescigno M; Ricciardi-Castagnoli P Eur J Immunol; 1996 Nov; 26(11):2595-600. PubMed ID: 8921944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]